Lead Product(s) : Caprylic Acid
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase II
Sponsor : Meridian Bioscience
Deal Size : Inapplicable
Deal Type : Inapplicable
Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)
Details : Sodium Octanoate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Metabolic Syndrome.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 19, 2010
Lead Product(s) : Caprylic Acid
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II
Sponsor : Meridian Bioscience
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
